# Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

> **NCT00450723** · NA · COMPLETED · sponsor: **University of Miami** · enrollment: 39 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Isosulfan blue
- **PROCEDURE:** Axillary Lymph Node Dissection
- **PROCEDURE:** Surgery
- **PROCEDURE:** Sentinel Lymph Node Biopsy
- **PROCEDURE:** Thoracoscopic Surgery
- **RADIATION:** Technetium Tc 99m Sulfur Colloid

## Key facts

- **NCT ID:** NCT00450723
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2011-01
- **Final completion:** 2011-03
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00450723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00450723, "Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00450723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*